New search | Conferencedetail
Print view

Anti-Fibrotic Drug Development Summit (AFDD)

evvnt Platform / evvnt
Conference themes
This Anti-Fibrotic Drug Development conference will be a unique opportunity for drug developers focused on organ-specific indications to participate in a cross-disciplinary, multi-organ discussions in order to gain new insights into their anti-fibrotic drug development research.

Attending this comprehensive forum will enable you to; identify which fibrotic mechanisms are driving pathology changes in humans; effectively translate from preclinical to clinical development.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)

Enquiries and Registration:
Mr. Customer Services
General Medicine
Congress fees
USD 2.699,00
(Register by August 18 to save $300: USD 2399, Register by September 8 to save $200: USD 2499, Register by October 6 to save $100: USD 2599, Standard Rate: USD 2699.)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Ärzte der WeltÖsterreichisches Rotes KreuzCharité International AcademynewTreeHilfswerk AustriaFFG - 7. EU-Rahmenprogramm


Give us your professional opinion

Start survey

Start survey